![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2016
Heldmann, F.; Baraliakos, X.; Kiltz, U.; Brandt, J.; Horst-Bruinsma, I. E. van der; Landewe, R.; Sieper, J.; Burmester, G. R.; Bosch, F. van den; Vlam, K. de; Gaston, H.; Gruenke, M.; Witt, M.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M. und Braun, J.
(2016):
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
In: Clinical and Experimental Rheumatology, Bd. 34, Nr. 2: S. 184-190
2014
Baraliakos, X.; Heldmann, F.; Callhoff, J.; Listing, J.; Appelboom, T.; Brandt, J.; Bosch, Frank van den; Breban, M.; Burmester, G. R.; Dougados, M.; Emery, P.; Gaston, H.; Grunke, M.; Horst-Bruinsma, I. E. van der; Landewe, R.; Leirisalo-Repo, M.; Sieper, J.; De Vlam, K.; Pappas, D.; Kiltz, U.; Heijde, D. van der und Braun, J.
(Oktober 2014):
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography.
In: Annals of the rheumatic diseases, Bd. 73, Nr. 10: S. 1819-1825
[PDF, 2MB]
2009
Emery, P.; Van Vollenhoven, R.; Ostergaard, M.; Choy, E.; Combe, B.; Graninger, W.; Krüger, Klaus; Matucci-Cerinic, M.; Navarro, F.; van Riel, P.; Settas, L. und Steinfeld, S.
(2009):
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
In: Annals of the Rheumatic Diseases, Bd. 68, Nr. 8: S. 456-459
[PDF, 192kB]